Dr. Schmaier on Managing Cancer-Associated Thrombosis
Alvin H. Schmaier, MD, professor in the Department of Medicine and the Department of Pathology at Case Western Reserve University School of Medicine, discusses the management of patients with cancer-associated thrombosis.
Dr. Schmaier on the Secondary Management of Thrombosis in Hematologic Malignancies
Alvin H. Schmaier, MD, discusses the secondary management of thrombosis in patients with hematologic malignancies.
Dr. Schmaier on Managing Thrombosis in Hematologic Malignancies
Alvin H. Schmaier, MD, discusses managing thrombosis in patients with hematologic malignancies.
Continued ADC Development in NSCLC Necessitates Improved Knowledge of Mechanisms and Biomarker Optimization
Neoadjuvant vs Perioperative Immune Checkpoint Blockade in Resectable NSCLC: How Do We Choose?
EGFR TKI–Based Combinations May Revolutionize Frontline EGFR+ NSCLC Management
Dr Olazagasti on a Case-Based Discussion of ALK-Mutated NSCLC Treatment
2 Commerce Drive Cranbury, NJ 08512